Thousands of leprosy patients across Nigeria have been left without essential medication for over a year, raising serious concerns about their health and well-being. According to medical experts and humanitarian organizations, at least 3,000 people, including 800 children, have gone without treatment due to delays in the delivery of multi-drug therapy (MDT), the standard treatment for leprosy.
The medication, which is supplied by the World Health Organization (WHO) and produced in India, was expected to arrive in early 2024 but only reached Nigeria on March 9, 2025. Health professionals warn that the damage may already be severe, as untreated leprosy can lead to permanent disabilities and increased transmission within communities.
Leprosy, also known as Hansen’s disease, is a chronic infectious condition caused by the bacterium Mycobacterium leprae. It primarily affects the skin, nerves, and mucous membranes, leading to disfigurement and severe nerve damage if left untreated. Although curable with MDT, delays in treatment increase the risk of complications and social stigma, making early intervention critical.
Dr. Adebayo Adekunle, a dermatologist specializing in infectious diseases, expressed deep concern over the situation, stating that many patients had been left vulnerable to worsening symptoms. He emphasized that the lack of medication over the past year has caused avoidable suffering, particularly among children. He also warned that Nigeria risks seeing a rise in new cases due to prolonged gaps in treatment.
Humanitarian organizations and local health agencies have called for improved coordination between government authorities and international suppliers to prevent such delays in the future. Reports from leprosy colonies and healthcare facilities indicate that some patients developed severe complications due to the treatment gap.
The Nigerian government has assured the public that efforts are being made to ensure smooth distribution of the long-awaited medication. Authorities have also pledged to strengthen the supply chain system for essential medicines to prevent similar crises in the future. However, health advocates stress that beyond distribution, efforts must be made to support those who have suffered due to the delay, including rehabilitation programs for those affected by permanent disabilities.
Nigeria remains one of the countries still battling leprosy, despite global efforts to eliminate the disease. Experts urge continued awareness campaigns, early diagnosis programs, and consistent drug supply to prevent the further spread of the disease and protect vulnerable communities.
Post a Comment